Biocure Technology Inc (TSE:CURE) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Biocure Technology Inc. has announced the mutual termination of its previously planned acquisition of Atriva Therapeutics, with no penalties incurred by either party. The agreement’s conclusion comes after an inability to complete the transaction within the set timeframe. Consequently, Biocure’s halted shares are anticipated to resume trading on the Canadian Stock Exchange subject to regulatory approval.
For further insights into TSE:CURE stock, check out TipRanks’ Stock Analysis page.
